Health regulators approve Oxford University and AstraZenica coronavirus vaccine



The Government has today authorised the Oxford University and AstraZenica coronavirus vaccination for use in the population.

Following analysis and testing from the Medicines and Healthcare products Regulatory Agency (MHRA), the Government confirmed the inoculation met the test required for approval.

The Joint Committee on Vaccination and Immunisation (JCVI) will also publish its latest advice for the priority groups to receive this vaccine.

Thousands of people have already received the first vaccine to be approved, by Pfizer/BioNTech, and the NHS will now continue to rollout both.

The Government says priority will be given to making sure those considered at risk get their first batch sooner, rather than rushing through the two batches in quick succession.

A Department of Health and Social Care spokesman said: “With two vaccines now approved, we will be able to vaccinate a greater number of people who are at highest risk, protecting them from the disease and reducing mortality and hospitalisation.

“The JCVI’s independent advice is that this approach will maximise the benefits of both vaccines. It will ensure that more at-risk people are able to get meaningful protection from a vaccine in the coming weeks and months, reducing deaths and starting to ease pressure on our NHS.

“To aid the success of the vaccination programme, it is vital everyone continues to play their part, abides by the restrictions in their area and remembers hands, face, space so we can suppress this virus and allow the NHS to do its work without being overwhelmed.”

Top stories on StokeonTrentLive

The approval of a second vaccine comes on the day Health Secretary Matt Hancock will reveal what coronavirus restriction tier each area is in.

He will address the House of Commons later.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *